Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

J&J pleads guilty over children’s contaminated medicine

March 12, 2015 Manufacturing and Production, Sales and Marketing FDA, J&J, JJ, McNeil, OTC, Tylenol, consta, hamburg, recall

Johnson & Johnson’s consumer division McNeil has pleaded guilty and will pay fines of $25 million for wrongdoings regarding its …
News

NHS backtracks on Cancer Drugs Fund de-listings

March 12, 2015 Sales and Marketing Afinitor, CDF, Cancer Drugs Fund, England, Halaven, NHS, Novartis, everolimus

NHS England is expected to perform a U-turn on several decisions to remove treatments from the cancer drugs fund when …
News

Endo attempts to outbid Valeant for Salix Pharma

March 12, 2015 Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix

Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …
News

GSK picks Singapore for Asian hub

March 12, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Asia, GSK, Singapore, Takeda, Witty, emerging markets

Despite GlaxoSmithKline’s ongoing troubles in Asia it has decided to establish a new HQ in Singapore to bolster its presence …
News

UCB sponsors ‘Hack Epilepsy’ digital event

March 12, 2015 Medical Communications, Sales and Marketing Keppra, UCB, epilepsy, hack, lacosamide, levetiracetam, vimpat

Belgian biopharma firm UCB says it will be sponsoring a ‘Hack Epilepsy’ event this year to help support patient needs …
News

Adaptimmune appoints PwC head to board

March 12, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lawrence Alleva, adaptimune, pwC

Clinical-stage biotech firm Adaptimmune has appointed Lawrence Alleva as a non-executive director who is also to serve as chairman of its …
Appointment

Merck’s cancer drug sees first ever early access nod

March 11, 2015 Sales and Marketing Cancer, ICR, Merck, eams, early access, keytruda, melanoma, oncology, pembrolizumab

Merck’s skin cancer drug Keytruda has become the first drug to be approved through the new Early Access to Medicines …
News

Merck Serono bets on precision medicine

March 11, 2015 Sales and Marketing AstraZeneca, Diagnostics, FDA, Illumina, Merck Serono, opexa, personalised

Merck Serono is looking to expand further into personalised medicine as the company enters into an agreement with Illumina to …
News

GSK China scandal leads to staff conflict

March 11, 2015 Sales and Marketing China, GSK, GlaxoSmithKline, bribery, chinese, cuts, sacked

Around 135 workers who face being removed from their posts by GlaxoSmithKline due to misconduct centering on bribery scandals in …
News

Government pledges ‘new era’ for NHS

March 11, 2015 Research and Development, Sales and Marketing NHS, Simon Stevens, five year, reform, reorganisation, vanguard

The government is investing £200 million to back healthcare professionals to implement their own ideas for improving patient care. The …
News

New details of Innovative Medicines review disclosed

March 11, 2015 Research and Development, Sales and Marketing ABPI, NHS, NICE, PPRS, UK, george freeman, innovative medicines

The government has announced details of a sweeping review into how medicines are accessed in the UK. The Innovative Medicines …
News

NICE approves Roche’s Gazyvaro and Novartis’ Xolair

March 11, 2015 Research and Development, Sales and Marketing Gazyvaro, NICE, Novartis, Roche, Xolair, obinutuzumab, omalizumab

NICE today gave the green light to three new biological drugs, after recommending Roche’s Gazyvaro, GSK’s Arzerra and Novartis’ Xolair …
News

New head of digital for Virgo Health

March 11, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, tom griffiths

UK-based healthcare comms agency Virgo Health has increased its leadership team through the appointment of Tom Griffiths as head of digital.  …
Appointment

HRT pills linked to increase in clots and strokes

March 10, 2015 Research and Development, Sales and Marketing Cochrane, HRT, boardman, hormone replacement therapy

HRT tablets do not offer heart benefits and slightly increase the risk of strokes and blood clots in some women. …
News

German court rules against Lilly in Alimta patent case

March 10, 2015 Manufacturing and Production, Sales and Marketing ACS, Actavis, Alimta, NICE, NSCLC, lilly, lung cancer, pemetrexed

A German court has ruled that Lilly’s patent for its lung cancer drug Alimta would not be infringed by generic …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026